Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Synthesis of dammarane-type triterpene derivatives and their ability to inhibit HIV and HCV proteases.

Wei Y, Ma CM, Hattori M.

Bioorg Med Chem. 2009 Apr 15;17(8):3003-10. doi: 10.1016/j.bmc.2009.03.019. Epub 2009 Mar 14.

PMID:
19339186
2.

[Inhibitory effects of some traditional medicines on proliferation of HIV-1 and its protease].

Nakamura N.

Yakugaku Zasshi. 2004 Aug;124(8):519-29. Review. Japanese.

3.

Molecular targets of anti-HIV-1 triterpenes.

Huang L, Chen CH.

Curr Drug Targets Infect Disord. 2002 Mar;2(1):33-6. Review.

PMID:
12462151
4.

Discovery and clinical development of HIV-1 protease inhibitors.

Huff JR, Kahn J.

Adv Protein Chem. 2001;56:213-51. Review. No abstract available.

PMID:
11329855
5.

Antiviral drug discovery targeting to viral proteases.

Hsu JT, Wang HC, Chen GW, Shih SR.

Curr Pharm Des. 2006;12(11):1301-14. Review.

PMID:
16611117
6.

Viral proteases as targets for chemotherapeutic intervention.

Hellen CU, Wimmer E.

Curr Opin Biotechnol. 1992 Dec;3(6):643-9. Review.

PMID:
1369416
7.

Plant-derived terpenoids and analogues as anti-HIV agents.

Sun IC, Kashiwada Y, Morris-Natschke SL, Lee KH.

Curr Top Med Chem. 2003;3(2):155-69. Review.

PMID:
12570771
8.

Betulinic acid and its derivatives: a review on their biological properties.

Yogeeswari P, Sriram D.

Curr Med Chem. 2005;12(6):657-66. Review.

PMID:
15790304
9.

Viral proteases.

Tong L.

Chem Rev. 2002 Dec;102(12):4609-26. Review. No abstract available.

PMID:
12475203
10.

[Current status of HIV protease inhibitors].

Yang QG, He XC, Bai DL.

Yao Xue Xue Bao. 2005 May;40(5):389-94. Review. Chinese. No abstract available.

PMID:
16220778
11.

Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues.

Brown NA.

Expert Opin Investig Drugs. 2009 Jun;18(6):709-25. doi: 10.1517/13543780902854194 . Review.

PMID:
19426125
12.

[Biological activity and pharmacological prospects of lupane terpenoids: II. Semisynthetic lupane derivatives].

Tolstikova TG, Sorokina IV, Tolstikov GA, Tolstikov AG, Flekhter OB.

Bioorg Khim. 2006 May-Jun;32(3):291-307. Review. Russian.

PMID:
16808172
13.

Boceprevir, an NS3 protease inhibitor of HCV.

Berman K, Kwo PY.

Clin Liver Dis. 2009 Aug;13(3):429-39. doi: 10.1016/j.cld.2009.05.008. Review.

PMID:
19628159
15.

Developments of indoles as anti-HIV-1 inhibitors.

Xu H, Lv M.

Curr Pharm Des. 2009;15(18):2120-48. Review.

PMID:
19519449
16.

Macrocyclic inhibitors of HCV NS3 protease.

Venkatraman S, Njoroge FG.

Expert Opin Ther Pat. 2009 Sep;19(9):1277-303. doi: 10.1517/13543770903044994. Review.

PMID:
19563268
17.

HIV/AIDS: recent advances in antiretroviral agents.

Nikolopoulos G, Bonovas S, Tsantes A, Sitaras NM.

Mini Rev Med Chem. 2009 Jul;9(8):900-10. Review.

PMID:
19601885
18.
19.

[Penetration in reservoirs].

Pasquau LiaƱo J.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:41-6. Review. Spanish.

PMID:
19572444
20.

Serine protease inhibitors as anti-hepatitis C virus agents.

Reiser M, Timm J.

Expert Rev Anti Infect Ther. 2009 Jun;7(5):537-47. doi: 10.1586/eri.09.30. Review.

PMID:
19485794

Supplemental Content

Support Center